Financial Review: Kymera Therapeutics (NASDAQ:KYMR) versus Ignyte Acquisition (NASDAQ:IGNY)
… for Kymera Therapeutics and Ignyte Acquisition, as provided by MarketBeat. Sell … malignancies and solid tumors, as well as autoimmune diseases and fibrosis; … intends to effect a merger, share [...]
